Unlike in the western Sweden series, GIST FGL2 expression did not have independent prognostic value when entered as a covariable into a Cox's multivariable analysis together with tumour mitotic count (as a continuous variable), tumour size (as a continuous variable), tumour site (gastric vs nongastric), tumour rupture (no vs yes) and adjuvant imatinib duration (12 vs. 36 months), whereas each of the other covariables were significantly associated with RFS (p < 0.01 for each covariable). Here, FGL2 is linked to neoplasm.